Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 1,3,5 -triazine based PI3K inhibitors as anticancer agents and a process for the preparation thereof

1,3,5 -triazine based PI3K inhibitors as anticancer agents and a process for the preparation thereof

US Patent 9951040 · Granted Apr 24, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Process for preparing non-cementitious loss control composition2025
Sustained release formulations of Dysoxylum binefacterum2025
Solid dispersion comprising an anticancer compound for improved solubility and e2024
Solid dispersion comprising an anticancer compound for improved solubility and e2024
Sustained release formulations of Crocus sativus2024
Phosphorylation of Syntaxin 17 by TBK1 controls autophagy initiation2024
Sustained release formulations of dysoxylum binefacterum2024
Gastroretentive sustained release formulations of Bergenia ciliata2022
Process for THR preparation of natural crystallized thymol from Monarda citriodo2021
Fused pyrimidines as isoform selective phosphoinositide-3-kinase-alpha inhibitor2020
Fused pyrimidines as isoform selective phosphoinositide-3-kinase-alpha inhibitor2020
Fused pyrimidines as isoform selective phosphoinositide-3-kinase-alpha inhibitor2020